In-silico Analysis of a Novel MCR-1.1 Variant on an IncX4 Plasmid Attenuating Colistin Resistance in Multidrug-Resistant Escherichia coli ST131
Infection and Drug Resistance · 2025-08 · Volume 18 · 4053-4066
DOI: 10.2147/idr.s539110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2025-08. Verfasst von Xinye Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
The emergence of mcr-1.1-mediated colistin resistance in Escherichia coli poses a significant threat to last-resort antibiotic therapy. This study investigates a novel variant of mcr-1.1 found in a highly virulent E. coli ST131 strain isolated from a pediatric patient with severe aplastic anemia and recurrent infections.
Methods
Blood samples were collected from a 4-year-old patient, and the E. coli isolate underwent antimicrobial susceptibility testing, multi-locus sequence typing, serotyping, and whole-genome sequencing. In-silico analyses included molecular docking and molecular dynamics simulations to assess the structural and functional impact of the mcr-1.1 variant. Horizontal gene transfer experiments evaluated plasmid mobility.
Results
The E. coli ST131 isolate harboured a mcr-1.1 gene located on a stable IncX4 plasmid and exhibited a multidrug-resistant phenotype. A missense mutation (T797C) led to an F265L substitution in the MCR-1.1 enzyme, reducing its phosphoethanolamine transferase activity. This mutation likely impairs lipid A modification, decreasing colistin resistance. Molecular modeling supported the reduced binding affinity of the mutated MCR-1.1 for lipid A. The plasmid demonstrated a horizontal transfer frequency of 1.3 × 10-². Phylogenetic analysis showed close relatedness to global ST131 clones.
Conclusion
This novel mcr-1.1 variant potentially restores colistin susceptibility in a globally prevalent E. coli lineage. The findings highlight a unique resistance attenuation mechanism and offer a promising avenue for restoring colistin efficacy. Further in-vivo validation is warranted to explore therapeutic strategies exploiting such mutations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
- Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, People's Republic of China.
- Department of Paediatrics, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.
- Department of Laboratory Medicine, Shenzhen Children's Hospital, Shenzhen, Guangdong, People's Republic of China.
ORCID-Profile: Sandip Patil
Zitieren
APA
Li, X., Chen, H., Chen, Y., Chen, X., Liu, S., Patil, S., & Wen, F. (2025). In-silico Analysis of a Novel MCR-1.1 Variant on an IncX4 Plasmid Attenuating Colistin Resistance in Multidrug-Resistant Escherichia coli ST131. Infection and Drug Resistance, Volume 18, 4053-4066. https://doi.org/10.2147/idr.s539110
Vancouver
Li X, Chen H, Chen Y, Chen X, Liu S, Patil S, et al. In-silico Analysis of a Novel MCR-1.1 Variant on an IncX4 Plasmid Attenuating Colistin Resistance in Multidrug-Resistant Escherichia coli ST131. Infection and Drug Resistance. 2025;Volume 18:4053-4066. doi:10.2147/idr.s539110
BibTeX
@article{Li2025,
author = {Li, Xinye and Chen, Hongyu and Chen, Yunsheng and Chen, Xiaowen and Liu, Sixi and Patil, Sandip and Wen, Feiqiu},
title = {In-silico Analysis of a Novel MCR-1.1 Variant on an IncX4 Plasmid Attenuating Colistin Resistance in Multidrug-Resistant Escherichia coli ST131},
journal = {Infection and Drug Resistance},
year = {2025},
volume = {Volume 18},
pages = {4053--4066},
doi = {10.2147/idr.s539110}
}
EUVIMED